144 related articles for article (PubMed ID: 25350803)
21. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
22. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
23. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB
Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480
[TBL] [Abstract][Full Text] [Related]
24. EORTC QLQ-C30 and FACT-Lym for the assessment of health-related quality of life of newly diagnosed lymphoma patients undergoing chemotherapy.
Georgakopoulos A; Kontodimopoulos N; Chatziioannou S; Niakas D
Eur J Oncol Nurs; 2013 Dec; 17(6):849-55. PubMed ID: 23850411
[TBL] [Abstract][Full Text] [Related]
25. Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients.
Chang YJ; Liang WM; Wu HC; Lin HC; Wang JY; Li TC; Yeh YC; Chang CH
Health Qual Life Outcomes; 2012 Aug; 10():96. PubMed ID: 22901052
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
27. Impacts of leuprolide acetate on quality of life in patients with prostate cancer: a prospective multicenter study.
You D; Jeong IG; Kim SW; Chung BH; Cho JS; Lee HM; Yun SC; Kim CS
Scand J Urol Nephrol; 2010 Dec; 44(6):399-405. PubMed ID: 20707648
[TBL] [Abstract][Full Text] [Related]
28. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
Chow E; Nguyen J; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bottomley A;
Cancer; 2012 Mar; 118(5):1457-65. PubMed ID: 21837676
[TBL] [Abstract][Full Text] [Related]
29. Osteoporosis risk and interest in strength training in men receiving androgen ablation therapy for locally advanced prostate cancer.
Ott C; Fulton MK
J Am Acad Nurse Pract; 2005 Mar; 17(3):113-22. PubMed ID: 15748224
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of maximal androgen blockade in prostate cancer patients at a health area with type 2 reference hospital. Part 2. Quality of life: application of EORTC QLQ-PR25 instrument and global results. Quality-of-life adjusted survival. Pharmaceutical expenses and cost-utility.
Guerra NA
Arch Esp Urol; 2009 Sep; 62(7):543-70. PubMed ID: 19815968
[TBL] [Abstract][Full Text] [Related]
31. Measurement of quality of life in men with prostate cancer.
Albaugh J; Hacker ED
Clin J Oncol Nurs; 2008 Feb; 12(1):81-6. PubMed ID: 18258577
[TBL] [Abstract][Full Text] [Related]
32. [Current developments in measuring quality of life with instruments of the European organisation for research and treatment of cancer (EORTC)].
Singer S; Hofmeister D; Spiegel K; Boehm A
Laryngorhinootologie; 2011 Oct; 90(10):591-4. PubMed ID: 22016255
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the EORTC STO-22 and the FACT-Ga quality of life questionnaires for patients with gastric cancer.
Woo A; Fu T; Popovic M; Chow E; Cella D; Wong CS; Lam H; Pulenzas N; Lechner B; Vuong S; Ganesh V; Bottomley A
Ann Palliat Med; 2016 Jan; 5(1):13-21. PubMed ID: 26841811
[TBL] [Abstract][Full Text] [Related]
34. [The critical appraisal of QOL questionnaire for prostate cancer patients].
Niimi M; Takeshima H; Hinotsu A; Takahashi H; Kano K; Otani M; Ishikawa S; Noguchi R; Oda E; Ohashi Y; Akaza H
Gan To Kagaku Ryoho; 1999 Feb; 26(3):333-43. PubMed ID: 10065097
[TBL] [Abstract][Full Text] [Related]
35. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
36. Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer.
Sullivan PW; Mulani PM; Fishman M; Sleep D
Qual Life Res; 2007 May; 16(4):571-5. PubMed ID: 17294287
[TBL] [Abstract][Full Text] [Related]
37. French version of FACT-G: validation and comparison with other cancer-specific instruments.
Conroy T; Mercier M; Bonneterre J; Luporsi E; Lefebvre JL; Lapeyre M; Puyraveau M; Schraub S
Eur J Cancer; 2004 Oct; 40(15):2243-52. PubMed ID: 15454249
[TBL] [Abstract][Full Text] [Related]
38. Cross-sectional validation study of patient-reported outcomes in patients with paroxysmal nocturnal haemoglobinuria.
Weitz I; Meyers G; Lamy T; Cahn JY; Uranga MT; García Vela JA; Sanz MA; Severino B; Kelly RJ; Hillmen P; Hill A
Intern Med J; 2013 Mar; 43(3):298-307. PubMed ID: 22909078
[TBL] [Abstract][Full Text] [Related]
39. Health-related quality of life in pain-free or mildly symptomatic patients with metastatic hormone-resistant prostate cancer following treatment with the specific endothelin A receptor antagonist zibotentan (ZD4054).
Dawson N; Payne H; Battersby C; Taboada M; James N
J Cancer Res Clin Oncol; 2011 Jan; 137(1):99-113. PubMed ID: 20390429
[TBL] [Abstract][Full Text] [Related]
40. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
